Age Ageing 19:419424 Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Niemi M, Neuvonen PJ et al (2011) Pharmacokinetics of intravenous paracetamol in elderly patients
2mg/mL CONCENTRATION~1mL vial .25mg= 12.5 units (0.125mL) .5mg=25 units (0.25mL) 1mg=50 units (0.5mL) 1.7mg= 85 units 2.4mg=120units 2.5/mL CONCENTRATION~ 2mL Vial .25mg=10units(0.1mL) .5mg=20units (0.2mL) 1.0mg= 40 units (0.4mL) 1.7mg=68units (0.68mL) 2.4mg=96units (0.96mL) 5mg/mL CONCENTRATION~2 ml Vial .25mg = 5 units (.05mL) .5mg = 10 units (0.1mL) 1mg= 20 units (0.2mL) 1.7 mg = 34 units (0.34mL) 2.4mg= 48 units(0.48mL) lnjections are subcutaneous once a week Vial must be refrigerated
Is refrigeration necessary for tirzepatide before first use
The SURMOUNT-5 trial (NEJM, 2025) found that tirzepatide produced an average weight loss of 20.2% versus 13.7% for semaglutide over 72 weeks a clinically meaningful difference
The Precision Peptide Genetic Test identifies whether your genetic profile favors tirzepatide, semaglutide, oral formulations, or a dual-compound approach like GLP-Squared, giving you personalized guidance rather than a one-size-fits-all recommendation
